Lista de obras - Ivo Kwee - Dominio Público Uruguay

13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia

artículo científico

A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma: an integrated genomics approach reveals a wide gene dosage effect

artículo científico publicado en 2009

A virtual tissue bank for primary central nervous system lymphomas in immunocompetent individuals

artículo científico publicado en 2007

Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma

artículo científico publicado en 2011

Anaplastic lymphoma kinase in human cancer

artículo científico publicado en 2011

Bromodomain and extra-terminal domain inhibition modulates the expression of pathologically relevant microRNAs in diffuse large B-cell lymphoma

scientific article published on 03 August 2018

Characterization of a mantle cell lymphoma cell line resistant to the Chk1 inhibitor PF-00477736

artículo científico publicado en 2015

Chromosome 11q23.1 is an unstable region in B-cell tumor cell lines.

artículo científico publicado en 2011

Comparative genome-wide profiling of post-transplant lymphoproliferative disorders and diffuse large B-cell lymphomas

artículo científico publicado en 2006

Concomitant MYC and microRNA cluster miR-17-92 (C13orf25) amplification in human mantle cell lymphoma

artículo científico publicado en 2007

DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features

artículo científico publicado en 2015

Del(13q14.3) length matters: an integrated analysis of genomic, fluorescence in situ hybridization and clinical data in 169 chronic lymphocytic leukaemia patients with 13q deletion alone or a normal karyotype

artículo científico publicado en 2011

Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphoma

artículo científico publicado en 2013

Diffuse large B cell lymphoma cell of origin by digital expression profiling in the REAL07 Phase 1-2 study

artículo científico publicado en 2017

Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome.

artículo científico publicado en 2011

Discovering subgroups of patients from DNA copy number data using NMF on compacted matrices

artículo científico publicado en 2013

Distinct patterns of global promoter methylation in early stage chronic lymphocytic leukemia

artículo científico publicado en 2013

Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP

Genome wide DNA-profiling of HIV-related B-cell lymphomas

artículo científico publicado en 2009

Genome-wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion

article

Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia.

artículo científico publicado en 2011

Genome-wide DNA profiling identifies clonal heterogeneity in marginal zone lymphomas.

artículo científico publicado en 2013

Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome

scientific article published on 29 November 2010

Genome-wide promoter methylation of hairy cell leukemia

scientific article published on 01 February 2019

Genomic aberrations affecting the outcome of immunodeficiency-related diffuse large B-cell lymphoma

scientific article published on 28 August 2011

Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21.

artículo científico publicado en 2010

Genomic profiles of MALT lymphomas: variability across anatomical sites

artículo científico publicado en 2011

Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas

High density genome-wide DNA profiling reveals a remarkably stable profile in hairy cell leukaemia.

artículo científico publicado en 2008

Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma

artículo científico publicado en 2012

Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts

artículo científico publicado en 2015

Immunogenetics features and genomic lesions in splenic marginal zone lymphoma

artículo científico publicado en 2010

Integrated DNA copy number and methylation profiling of lymphoid neoplasms using a single array

artículo científico publicado en 2011

Integrated profiling of diffuse large B-cell lymphoma with 7q gain

artículo científico publicado en 2011

Molecular characterization of human multiple myeloma cell lines by integrative genomics: insights into the biology of the disease.

artículo científico publicado en 2007

Non-negative matrix factorization to perform unsupervised clustering of genome wide DNA profiles in mature B cell lymphoid neoplasms

scientific article published on 28 April 2010

PCSF: An R-package for network-based interpretation of high-throughput data.

artículo científico publicado en 2017

PQR309 Is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas as a Single Agent and in Combination Therapy.

artículo científico publicado en 2017

PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma

artículo científico publicado en 2013

Population-based outcome analysis of diffuse large B-cell lymphoma in people living with HIV infection and competent individuals

article

Preclinical evaluation of the BET bromodomain inhibitor BAY 1238097 for the treatment of lymphoma.

artículo científico publicado en 2017

Promoter methylation patterns in Richter syndrome affect stem-cell maintenance and cell cycle regulation and differ from de novo diffuse large B-cell lymphoma

artículo científico publicado en 2013

Role of ETS1 in the Transcriptional Network of Diffuse Large B Cell Lymphoma of the Activated B Cell-Like Type

artículo científico publicado en 2020

Saliva is a reliable and practical source of germline DNA for genome-wide studies in chronic lymphocytic leukemia.

artículo científico publicado en 2011

Single nucleotide polymorphism-arrays provide new insights in the pathogenesis of post-transplant diffuse large B-cell lymphoma

article by Andrea Rinaldi et al published 3 March 2010 in British Journal of Haematology

The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs.

artículo científico publicado en 2015

The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents

scientific article published on 10 June 2019

The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas.

scientific article published on 03 March 2009

The Novel TORC1/2 Kinase Inhibitor PQR620 Has Anti-Tumor Activity in Lymphomas as a Single Agent and in Combination with Venetoclax

artículo científico publicado en 2019

The novel atypical retinoid ST5589 down-regulates Aurora Kinase A and has anti-tumour activity in lymphoma pre-clinical models.

artículo científico publicado en 2015

Therapeutic efficacy of the bromodomain inhibitor OTX015/MK-8628 in ALK-positive anaplastic large cell lymphoma: an alternative modality to overcome resistant phenotypes

artículo científico

Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome.

artículo científico publicado en 2013

Lista de obras de Ivo Kwee

13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia

A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma: an integrated genomics approach reveals a wide gene dosage effect

A virtual tissue bank for primary central nervous system lymphomas in immunocompetent individuals

Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma

Anaplastic lymphoma kinase in human cancer

Bromodomain and extra-terminal domain inhibition modulates the expression of pathologically relevant microRNAs in diffuse large B-cell lymphoma

Characterization of a mantle cell lymphoma cell line resistant to the Chk1 inhibitor PF-00477736

Chromosome 11q23.1 is an unstable region in B-cell tumor cell lines.

Comparative genome-wide profiling of post-transplant lymphoproliferative disorders and diffuse large B-cell lymphomas

Concomitant MYC and microRNA cluster miR-17-92 (C13orf25) amplification in human mantle cell lymphoma

DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features

Del(13q14.3) length matters: an integrated analysis of genomic, fluorescence in situ hybridization and clinical data in 169 chronic lymphocytic leukaemia patients with 13q deletion alone or a normal karyotype

Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphoma

Diffuse large B cell lymphoma cell of origin by digital expression profiling in the REAL07 Phase 1-2 study

Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome.

Discovering subgroups of patients from DNA copy number data using NMF on compacted matrices

Distinct patterns of global promoter methylation in early stage chronic lymphocytic leukemia

Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP

Genome wide DNA-profiling of HIV-related B-cell lymphomas

Genome-wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion

Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia.

Genome-wide DNA profiling identifies clonal heterogeneity in marginal zone lymphomas.

Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome

Genome-wide promoter methylation of hairy cell leukemia

Genomic aberrations affecting the outcome of immunodeficiency-related diffuse large B-cell lymphoma

Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21.

Genomic profiles of MALT lymphomas: variability across anatomical sites

Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas

High density genome-wide DNA profiling reveals a remarkably stable profile in hairy cell leukaemia.

Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma

Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts

Immunogenetics features and genomic lesions in splenic marginal zone lymphoma

Integrated DNA copy number and methylation profiling of lymphoid neoplasms using a single array

Integrated profiling of diffuse large B-cell lymphoma with 7q gain

Molecular characterization of human multiple myeloma cell lines by integrative genomics: insights into the biology of the disease.

Non-negative matrix factorization to perform unsupervised clustering of genome wide DNA profiles in mature B cell lymphoid neoplasms

PCSF: An R-package for network-based interpretation of high-throughput data.

PQR309 Is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas as a Single Agent and in Combination Therapy.

PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma

Population-based outcome analysis of diffuse large B-cell lymphoma in people living with HIV infection and competent individuals

Preclinical evaluation of the BET bromodomain inhibitor BAY 1238097 for the treatment of lymphoma.

Promoter methylation patterns in Richter syndrome affect stem-cell maintenance and cell cycle regulation and differ from de novo diffuse large B-cell lymphoma

Role of ETS1 in the Transcriptional Network of Diffuse Large B Cell Lymphoma of the Activated B Cell-Like Type

Saliva is a reliable and practical source of germline DNA for genome-wide studies in chronic lymphocytic leukemia.

Single nucleotide polymorphism-arrays provide new insights in the pathogenesis of post-transplant diffuse large B-cell lymphoma

The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs.

The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents

The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas.

The Novel TORC1/2 Kinase Inhibitor PQR620 Has Anti-Tumor Activity in Lymphomas as a Single Agent and in Combination with Venetoclax

The novel atypical retinoid ST5589 down-regulates Aurora Kinase A and has anti-tumour activity in lymphoma pre-clinical models.

Therapeutic efficacy of the bromodomain inhibitor OTX015/MK-8628 in ALK-positive anaplastic large cell lymphoma: an alternative modality to overcome resistant phenotypes

Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome.